Concord Medical Financials
CCM Stock | USD 4.45 0.25 5.95% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.3 | 0.3163 |
|
|
Investors should never underestimate Concord Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Concord Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Concord Medical Services.
Cash And Equivalents |
|
Concord | Select Account or Indicator |
Understanding current and past Concord Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Concord Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Concord Medical's assets may result in an increase in income on the income statement.
Concord Medical Stock Summary
Concord Medical competes with Pennant, Encompass Health, Enhabit, National HealthCare, and American Shared. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US2062771058 |
CUSIP | 206277105 206277204 |
Location | China |
Business Address | East Zone, Hanwei |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.concordmedical.com |
Phone | 86 10 5903 6688 |
Currency | USD - US Dollar |
Concord Medical Key Financial Ratios
Return On Equity | -0.32 | ||||
Profit Margin | (0.80) % | ||||
Operating Margin | (0.90) % | ||||
Price To Sales | 0.04 X | ||||
Revenue | 537.4 M |
Concord Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.3B | 5.3B | 6.2B | 6.0B | 6.1B | 4.0B | |
Other Current Liab | 274.7M | 243.2M | 646.0M | 397.2M | 716.3M | 752.2M | |
Other Liab | 287.0M | 270.2M | 230.1M | 268.9M | 309.2M | 324.7M | |
Cash | 74.3M | 334.3M | 157.4M | 158.3M | 58.1M | 55.2M | |
Other Assets | 661.1M | 409.9M | 250.6M | 24.0M | 27.6M | 26.2M | |
Long Term Debt | 1.3B | 2.0B | 2.2B | 2.5B | 2.0B | 2.1B | |
Good Will | 210.4M | 213.7M | 581.9M | 575.4M | 661.7M | 694.8M | |
Other Current Assets | 4.3M | 31.4M | 258.4M | 386.4M | 445.2M | 467.5M | |
Total Liab | 2.4B | 2.9B | 3.5B | 4.0B | 4.3B | 4.5B | |
Intangible Assets | 532.5M | 522.8M | 1.1B | 762.1M | 323.3M | 435.8M | |
Net Debt | 1.8B | 2.0B | 2.6B | 3.1B | 3.2B | 3.4B | |
Retained Earnings | (1.8B) | (2.5B) | (3.3B) | (3.8B) | (4.1B) | (3.9B) | |
Accounts Payable | 8.3M | 18.6M | 102.5M | 146.7M | 129.2M | 135.7M | |
Net Receivables | 199.6M | 280.4M | 130.6M | 130.3M | 73.5M | 69.8M | |
Total Current Assets | 282.5M | 676.0M | 584.5M | 759.8M | 617.2M | 736.9M | |
Short Term Debt | 341.3M | 162.5M | 35.1M | 548.5M | 1.1B | 1.1B | |
Inventory | 4.3M | 21.6M | 38.1M | 84.8M | 40.3M | 28.3M | |
Net Tangible Assets | (865.7M) | (1.4B) | (2.6B) | (2.8B) | (2.5B) | (2.4B) | |
Short Long Term Debt | 328.4M | 148.9M | 299.4M | 512.6M | 1.0B | 537.8M |
Concord Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 28.7M | 81.4M | 73.8M | 120.4M | 165.7M | 174.0M | |
Total Revenue | 198.4M | 223.0M | 485.6M | 472.1M | 537.4M | 458.0M | |
Gross Profit | (15.8M) | 13.1M | (56.9M) | (152.4M) | (76.6M) | (72.8M) | |
Cost Of Revenue | 214.2M | 209.9M | 542.5M | 624.5M | 614.0M | 314.8M | |
Income Tax Expense | (39.0M) | (37.6M) | (6.6M) | (70.9M) | (24.6M) | (23.3M) | |
Operating Income | (437.3M) | (307.5M) | (458.3M) | (525.0M) | (463.0M) | (439.8M) | |
Ebit | (437.3M) | (307.5M) | (455.4M) | (719.5M) | (442.2M) | (420.1M) | |
Ebitda | (263.6M) | (206.4M) | (351.4M) | (586.7M) | (313.7M) | (298.1M) | |
Income Before Tax | (391.1M) | (441.7M) | (529.2M) | (839.9M) | (555.6M) | (527.8M) | |
Net Income | (352.1M) | (404.0M) | (820.6M) | (489.7M) | (297.7M) | (282.8M) | |
Minority Interest | 2.0B | 3.1B | 251.2M | 279.3M | 233.4M | 221.7M | |
Tax Provision | (39.0M) | (37.6M) | (6.6M) | (70.9M) | (24.6M) | (23.3M) | |
Interest Income | 10.4M | 8.4M | 5.9M | 10.0M | 10.8M | 18.1M | |
Net Interest Income | (19.5M) | (72.9M) | (67.9M) | (110.3M) | (154.8M) | (147.1M) |
Concord Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Capital Expenditures | 701.5M | 512.9M | 780.3M | 384.8M | 119.9M | 113.9M | |
End Period Cash Flow | 74.3M | 446.4M | 158.9M | 159.3M | 90.4M | 85.9M | |
Change To Netincome | 174.8M | 32.5M | (145.4M) | 35.1M | 40.4M | 31.6M | |
Change To Inventory | (1.8M) | (14.4M) | (4.4M) | (46.8M) | 44.5M | 46.7M | |
Change In Cash | (752.4M) | 372.1M | (287.5M) | 432K | (68.9M) | (65.5M) | |
Free Cash Flow | (896.8M) | (742.7M) | (1.1B) | (601.5M) | (396.4M) | (416.2M) | |
Depreciation | 56.4M | 80.3M | 104.1M | 132.8M | 128.5M | 91.0M | |
Other Non Cash Items | 176.6M | 119.3M | 79.9M | 392.2M | 194.1M | 101.8M | |
Net Income | (352.1M) | (404.0M) | (522.7M) | (769.0M) | (531.0M) | (504.5M) | |
Investments | (1.1B) | (239.3M) | (566.0M) | (118.8M) | (47.7M) | (50.1M) | |
Net Borrowings | 523.3M | 353.1M | 245.5M | 383.1M | 440.6M | 286.7M |
Concord Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Concord Medical's current stock value. Our valuation model uses many indicators to compare Concord Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Concord Medical competition to find correlations between indicators driving Concord Medical's intrinsic value. More Info.Concord Medical Services is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Concord Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Concord Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Concord Medical Services Systematic Risk
Concord Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Concord Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Concord Medical Services correlated with the market. If Beta is less than 0 Concord Medical generally moves in the opposite direction as compared to the market. If Concord Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Concord Medical Services is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Concord Medical is generally in the same direction as the market. If Beta > 1 Concord Medical moves generally in the same direction as, but more than the movement of the benchmark.
Concord Medical Thematic Clasifications
Concord Medical Services is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Healthcare | View |
Today, most investors in Concord Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Concord Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Concord Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Concord Medical November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Concord Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Concord Medical Services. We use our internally-developed statistical techniques to arrive at the intrinsic value of Concord Medical Services based on widely used predictive technical indicators. In general, we focus on analyzing Concord Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Concord Medical's daily price indicators and compare them against related drivers.
Information Ratio | (0.13) | |||
Maximum Drawdown | 41.12 | |||
Value At Risk | (8.15) | |||
Potential Upside | 7.85 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.98) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.